# Luis López Lázaro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luis-lopez-lazaro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,035 |
| Field | Synthesis and Biological Activity |
| h-index | 27 |
| i10-index | 48 |
| Last Known Institution | Swedish Orphan Biovitrum (United States) |
| OpenAlex ID | https://openalex.org/A5018880888 |
| ORCID iD | 0000-0003-0620-6133 |
| Works | 100 |

## Researcher papers

- [Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-ecteinascidin-743-a-new-marine-compound/)
- [Erythema nodosum: Etiologic and predictive factors in a defined population](https://scholariq.org/papers/erythema-nodosum-etiologic-and-predictive-factors-in-a-defined-population/)
- [Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies](https://scholariq.org/papers/phase-i-and-pharmacokinetic-study-of-aplidine-a-new-marine-cyclodepsipeptide-in/)
- [Yondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin](https://scholariq.org/papers/yondelis-trabectedin-et-743-the-development-of-an-anticancer-agent-of-marine/)
- [Phase I Clinical and Pharmacokinetic Study of Kahalalide F in Patients with Advanced Androgen Refractory Prostate Cancer](https://scholariq.org/papers/phase-i-clinical-and-pharmacokinetic-study-of-kahalalide-f-in-patients-with/)
- [A phase I and pharmacokinetic study of ecteinascidin-743 on a daily x 5 schedule in patients with solid malignancies.](https://scholariq.org/papers/a-phase-i-and-pharmacokinetic-study-of-ecteinascidin-743-on-a-daily-x-5-schedule/)
- [Pharmacokinetics and pharmacodynamics of the novel marine-derived anticancer agent ecteinascidin 743 in a phase I dose-finding study.](https://scholariq.org/papers/pharmacokinetics-and-pharmacodynamics-of-the-novel-marine-derived-anticancer/)
- [Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat.](https://scholariq.org/papers/complete-protection-by-high-dose-dexamethasone-against-the-hepatotoxicity-of-the/)
- [Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity](https://scholariq.org/papers/pharmacokinetics-of-ecteinascidin-743-administered-as-a-24-h-continuous/)
- [Drug associated cutaneous vasculitis in adults in northwestern Spain.](https://scholariq.org/papers/drug-associated-cutaneous-vasculitis-in-adults-in-northwestern-spain/)
- [Clinical Presentation, Treatment Patterns, Burden of Disease, and the Association of Proteinuria with Clinical Outcomes in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative Glomerulonephritis: A Systematic Review](https://scholariq.org/papers/clinical-presentation-treatment-patterns-burden-of-disease-and-the-association/)

## Researcher topics

- [Synthesis and Biological Activity](https://scholariq.org/topics/synthesis-and-biological-activity-2/)
- [Genetics, Bioinformatics, and Biomedical Research](https://scholariq.org/topics/genetics-bioinformatics-and-biomedical-research/)
- [Microbial Natural Products and Biosynthesis](https://scholariq.org/topics/microbial-natural-products-and-biosynthesis/)
- [Marine Sponges and Natural Products](https://scholariq.org/topics/marine-sponges-and-natural-products/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Swedish Orphan Biovitrum (United States)](https://scholariq.org/institutions/swedish-orphan-biovitrum-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.